Epa and dha
Pro Research Analysisby 
Searched over 200M research papers
The Differential Effects of EPA and DHA on Health
Introduction to EPA and DHA
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids known for their significant health benefits, particularly in reducing inflammation and improving cardiovascular health. Despite their similarities, EPA and DHA have distinct effects on various physiological processes.
Inflammatory Response Modulation
EPA and DHA on Monocyte Inflammatory Response
EPA and DHA differentially modulate the inflammatory response in monocytes. EPA supplementation has been shown to lower TNFA expression significantly, while DHA reduces TNFA, IL6, MCP1, and IL10 expressions. Notably, DHA has a broader effect in attenuating pro-inflammatory cytokines compared to EPA 1. This suggests that DHA might be more effective in reducing overall inflammation.
Gene Expression and Inflammation
Both EPA and DHA influence the expression of inflammation-related genes. EPA enhances TRAF3 and PPARA expression and lowers CD14 expression, while DHA increases PPARA and TNFA expression and decreases CD14 expression. These effects indicate that both fatty acids can modulate gene expression to exert anti-inflammatory effects, although their specific impacts may vary 8.
Cardiovascular Health
Blood Pressure and Lipid Profiles
EPA and DHA have been shown to affect blood pressure and lipid profiles differently. EPA significantly reduces systolic blood pressure, especially in individuals with dyslipidemia, while DHA significantly reduces diastolic blood pressure in the same group 3. Additionally, DHA is more effective than EPA in lowering serum triglycerides and increasing HDL cholesterol levels 27.
Triglyceride and Lipogenesis Regulation
DHA supplementation reduces blood triglycerides and increases lipoprotein lipase (LPL) activity, which aids in triglyceride clearance. In contrast, EPA does not significantly affect triglyceride levels but increases the lipogenic index, suggesting a different mechanism of action in lipid metabolism 2.
Bioavailability and Conversion
Bioavailability of EPA and DHA
A novel liquid crystalline nanoparticle-based formulation has been shown to significantly increase the bioavailability of both EPA and DHA compared to traditional soft capsules. This enhanced bioavailability could improve the clinical effectiveness of these fatty acids 5.
Conversion Between EPA and DHA
EPA can be converted into DHA in the human body, but DHA does not retroconvert to EPA. This conversion process highlights the metabolic flexibility and potential for DHA to contribute to EPA levels indirectly 9.
Conclusion
EPA and DHA, while both beneficial, have distinct effects on inflammation, cardiovascular health, and lipid metabolism. DHA appears to have a broader and more potent impact on reducing inflammation and improving lipid profiles compared to EPA. Understanding these differences can help tailor dietary and supplemental strategies to maximize health benefits.
Sources and full results
Most relevant research papers on this topic
EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
EPA and DHA supplementation both reduce chronic inflammation, with DHA having a broader effect in attenuating pro-inflammatory cytokines.
RCT
Highly CitedEPA and DHA have divergent effects on serum triglycerides and lipogenesis, but similar effects on lipoprotein lipase activity: a randomized controlled trial.
DHA supplementation lowers blood triglycerides, while EPA supplementation doesn't, possibly due to increased lipogenesis and LPL activity.
RCT
Very Rigorous JournalEffects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials
EPA and DHA both have independent (blood pressure) and shared (CRP concentration) effects on chronic disease risk factors, with EPA showing a greater reduction in systolic blood pressure and DHA in subjects with dyslipidemia.
Meta-AnalysisEPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
EPA+DHA supplementation improves lipids and inflammation status in hypercholesterolemic adults, while ALA supplementation does not increase EPA/DHA fatty acid composition in middle-aged to elderly Chinese individuals.
RCTVery Rigorous JournalA Randomized, Open-Label, Single-Dose, Crossover Study of the Comparative Bioavailability of EPA and DHA in a Novel Liquid Crystalline Nanoparticle-Based Formulation of ω-3 Acid Ethyl Ester Versus Omacor® Soft Capsule among Healthy Adults
The IMD-Omega soft cap significantly increases bioavailability of EPA and DHA compared to the Omacor® soft cap, potentially improving patient compliance and reducing dosages.
RCTAbstract 10318: Polyunsaturated Fatty Acids, EPA and DHA Possess a Potent P300-hat Inhibitor and Prevent Mi-Induced Development of Heart Failure in Rats
Both EPA and DHA effectively prevent heart failure development in rats with myocardial infarction by inhibiting p300-HAT activity.
RCT
Rigorous JournalA randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
DHA supplementation has greater anti-inflammatory effects and better blood lipid effects than EPA supplementation in men and women at risk of cardiovascular disease.
RCTVery Rigorous JournalHighly CitedInflammatory gene expression in whole blood cells after EPA vs. DHA supplementation: Results from the ComparED study.
High-dose EPA and DHA supplementation have similar effects on inflammation-related genes in immune cells of men and women at risk for cardiometabolic diseases.
RCTCompound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial.
DHA supplementation in humans increases plasma EPA due to a slower metabolism and accumulation, while substantial amounts of supplemental EPA can be converted into DHA.
RCTVery Rigorous JournalHighly CitedScientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)
The Tolerable Upper Intake Level (TUIL) for EPA, DHA, and DPA is 1.8 g/day for adults, with no significant adverse effects on cardiovascular disease risk.
Systematic ReviewHighly Cited